Tom Macpherson, Chief Investment Officer and Managing Director of Nintai Investments LLC.
Nintai is a boutique investment house with roughly $39M under management in individually managed accounts. The company focuses on small to mid-cap stocks with high returns (generally greater than 15% over the past decade) on capital, equity, and assets. Other investment criteria include little to no debt, high free cash flow margins, management who are outstanding capital allocators, and trade at significant discounts to their estimated intrinsic value. Since the company's inception in 2017, the annual aggregate fund investment returns through December 2020 have been 20.2% (net fees) versus 14.0% for the S&P 500.
Before establishing Nintai Investments, Macpherson was an investment manager at Dorfman Value Investments in Boston. From 2001 to 2015, he was Managing Director of Nintai Partners LLP, a healthcare-centric consulting firm that worked with corporate Boards and C-Suite members on corporate strategy, the future of healthcare informatics, and mergers & acquisitions. Macpherson managed an internal investment portfolio and the Nintai Charitable Trust with over $55M in assets under management. Macpherson is a former Board member of the Robert F Kennedy Center for Human Rights and Justice (now RFK Human Rights), the McKesson Technology Board, and the Hayashi Trust. He currently serves on the Harvard University Medical School Advisory Board, where he chairs the Informatics Committee. He is a graduate of Harvard University. He is also a Series 65 registered investment advisor.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here: https://www.gurufocus.com/membership/new/index.html#/?utm_campaign=podcast
Watch the full stream: https://youtu.be/ZhnlzEjW55U